GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis. TweetSharePlus oneShareEmail Related Posts GlycoMantra received SBIR Phase 1 grant from the NCI (NIH) July 18, 2018 GlycoMantra received SBIR Phase 1 grant from the NCI (NIH) GlycoMantra was… GlycoMantra received a CDMRP grant from the DOD. June 12, 2018 GlycoMantra received a CDMRP grant from the DOD. GlycoMantra was awarded a… GlycoMantra received Investor Initiative Award from the NCI (NIH). July 2017 GlycoMantra received Investor Initiative Award from the NCI (NIH). Through this mechanism,…
GlycoMantra received SBIR Phase 1 grant from the NCI (NIH) July 18, 2018 GlycoMantra received SBIR Phase 1 grant from the NCI (NIH) GlycoMantra was…
GlycoMantra received a CDMRP grant from the DOD. June 12, 2018 GlycoMantra received a CDMRP grant from the DOD. GlycoMantra was awarded a…
GlycoMantra received Investor Initiative Award from the NCI (NIH). July 2017 GlycoMantra received Investor Initiative Award from the NCI (NIH). Through this mechanism,…
